These findings suggest that IRF-3-TBK-1 pathway in Berb-treated mice stimulates IFN-β, IFITM, and antiviral genes (OAS1g, MX2) and downregulates CXCL10, thereby mitigating lung injury, viral pneumonia and inflammation compared to infection group. This evidence concerns the gene MX2 and viral pneumonia.